|
AZI2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62447832963153E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
1.66129998646625E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
4.662600E-01 |
| Stage1-vs-Stage3 |
4.039800E-02 |
| Stage1-vs-Stage4 |
1.413770E-02 |
| Stage2-vs-Stage3 |
4.047900E-02 |
| Stage2-vs-Stage4 |
3.018500E-02 |
| Stage3-vs-Stage4 |
6.755800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
4.70409999842047E-08 |
| Normal-vs-Asian |
4.66426897105521E-12 |
| Caucasian-vs-AfricanAmerican |
2.403400E-01 |
| Caucasian-vs-Asian |
9.761800E-02 |
| AfricanAmerican-vs-Asian |
9.697800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
6.208400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
1.83167999999734E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.903000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.620800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.568000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.212000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.614200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.064400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.083100E-03 |
| Classical-VS-Follicular |
7.792200E-02 |
| Classical-VS-Other |
3.748400E-01 |
| Classical-VS-Normal |
1.11022302462516E-15 |
| Tall-VS-Follicular |
6.193000E-04 |
| Tall-VS-Other |
7.681600E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
2.473400E-01 |
| Follicular-VS-Normal |
4.58360016608594E-10 |
| Other-VS-Normal |
1.79353999999465E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
<1E-12 |
| N0-vs-N1 |
7.620400E-02 |
|
|
